| Ms Molly Anne Mchenry, LCSW | |
|
6455 Machine Street, Building 2501, Aberdeen Proving Ground, MD 21055 | |
| (410) 278-1827 | |
| Not Available |
| Full Name | Ms Molly Anne Mchenry |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 6455 Machine Street, Aberdeen Proving Ground, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558693788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 7429-C (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Molly Anne Mchenry, LCSW 6455 Machine St Bldg 2501, Aberdeen Proving Ground, MD 21005-5213 Ph: (410) 278-1827 | Ms Molly Anne Mchenry, LCSW 6455 Machine Street, Building 2501, Aberdeen Proving Ground, MD 21055 Ph: (410) 278-1827 |
News Archive
In the last few years, the benefits of short, intense workouts have been extolled by both researchers and exercise fans as something of a metabolic panacea capable of providing greater overall fitness, better blood sugar control and weight reduction-all of it in periods as short as seven minutes a few times a week.
NeuroDerm, Ltd. was informed today that it was awarded, for the second time, a grant of $1M by The Michael J. Fox Foundation for Parkinson's Research to support the clinical development of its subcutaneously delivered drug for the treatment of Parkinson's disease.
In their forthcoming paper, "The hidden impact of conspiracy theories: Perceived and actual influence of theories surrounding the death of Princess Diana", Dr Karen Douglas and Dr Robbie Sutton from the University of Kent show that people are persuaded by conspiracy theories about Princess Diana's death even though they do not necessarily know it.
Alexion Pharmaceuticals, Inc. today announced that the Company has completed its previously announced acquisition of 100% of the capital stock of Enobia Pharma Corp., a private biopharmaceutical company focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.
Halozyme Therapeutics, Inc. today announced that Roche has completed patient enrollment for the pivotal Phase 3 study of Herceptin SC (trastuzumab subcutaneous), a subcutaneous formulation that uses Halozyme's Enhanze™ technology (rHuPH20, recombinant human hyaluronidase).
› Verified 7 days ago
Ms. Joyce Decker Guidish, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2501 Oakington St, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1827 Fax: 410-278-1766 | |
Noel A Cuff, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2501 Oakington St, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1727 Fax: 410-278-1783 |